List of AgeneBio patents

List of AgeneBio patents

List of Magnolia Solar patents

List of Universal Laser Systems patents

List of Shop Vac Corporation patents

List of NGOs in Lincolnshire

Companies in the Drug metabolism industry

Patents where

Current Assignee

Name

is

AgeneBio

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11142529 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 11142529 was granted and assigned to AgeneBio on October, 2021 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	11142529	October 12, 2021
	‌ US Patent 10329301 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 10329301 was granted and assigned to AgeneBio on June, 2019 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	10329301	June 25, 2019
	‌ US Patent 9801879 Pyridazine derivatives, compositions and methods for treating cognitive impairment	Patent 9801879 was granted and assigned to AgeneBio on October, 2017 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	9801879	October 31, 2017
	‌ US Patent 9145372 Pyridazine derivatives, compositions and methods for treating cognitive impairment	Patent 9145372 was granted and assigned to AgeneBio on September, 2015 by the United States Patent and Trademark Office.		AgeneBio		United States Patent and Trademark Office	9145372	September 29, 2015
	‌ US Patent 11414425 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment		AgeneBio	AgeneBio		United States Patent and Trademark Office	11414425	August 16, 2022
	‌ US Patent 11312721 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 11312721 was granted and assigned to AgeneBio on April, 2022 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	11312721	April 26, 2022
	‌ US Patent 11505555 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 11505555 was granted and assigned to AgeneBio on November, 2022 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	11505555	November 22, 2022
	‌ US Patent 10815242 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 10815242 was granted and assigned to AgeneBio on October, 2020 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	10815242	October 27, 2020
	‌ US Patent 10159648 Extended release pharmaceutical compositions of levetiracetam	Patent 10159648 was granted and assigned to AgeneBio on December, 2018 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	10159648	December 25, 2018
	‌ US Patent 10925834 Extended release pharmaceutical compositions of levetiracetam	Patent 10925834 was granted and assigned to AgeneBio on February, 2021 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	10925834	February 23, 2021
	‌ US Patent 11160785 Methods and compositions for improving cognitive function	Patent 11160785 was granted and assigned to AgeneBio on November, 2021 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	11160785	November 2, 2021
	‌ US Patent 12024525 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment	Patent 12024525 was granted and assigned to AgeneBio on July, 2024 by the United States Patent and Trademark Office.	AgeneBio	AgeneBio		United States Patent and Trademark Office	12024525	July 2, 2024

12 results

0 selected

12 results

0 selected